Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120,538,577
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
2,603,081
-
Shares change
-
-49,311
-
Total reported value, excl. options
-
$10,549,000
-
Value change
-
-$229,537
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$4.06
Significant Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) as of Q3 2021
14 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value as of Q3 2021.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,603,081 shares
of 120,538,577 outstanding shares and own 2.16% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (1,200,000 shares), ARMISTICE CAPITAL, LLC (630,700 shares), VANGUARD GROUP INC (509,056 shares), GEODE CAPITAL MANAGEMENT, LLC (76,964 shares), EMC Capital Management (75,835 shares), BlackRock Inc. (33,470 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (26,635 shares), BANK OF AMERICA CORP /DE/ (24,806 shares), HRT FINANCIAL LP (13,453 shares), and NORTHERN TRUST CORP (10,584 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.